AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- July 2024 -
 
A comprehensive review of Prof... 8
Romanian Review of Laboratory ... 5
The usefulness of IS6110 neste... 3
α-HPV positivity analysis in ... 3
Phenotypic and genotypic study... 3
Prediction of acute pancreatit... 3
Monocyte to high-density lipop... 3
The role of nitro oxidative fa... 3
Diagnostic value of stress myo... 3
Assessment of ocrelizumab impa... 3

Log in

Concept, Design & Programming
Dr. Adrian Man

   
  Articles published by Rodica,Balasa
 
  1 Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients
    Authors: Smaranda Maier, Adina Huțanu, Laura Bărcuțean, Emanuela Sărmășan, Rodica Bălașa
   
     
  2 The direct deleterious effect of Th17 cells in the nervous system compartment in multiple sclerosis and experimental autoimmune encephalomyelitis: one possible link between neuroinflammation and neurodegeneration
    Authors: Rodica Balasa, Smaranda Maier, Laura Barcutean, Adina Stoian, Anca Motataianu
   
     
  3 Correction of the article: Plasma phosphorylated neurofilament heavy chains as a potential marker for ischemic stroke patients
    Authors: Adina Huțanu, Smaranda Maier, Rodica Bălaşa, Oana Roxana Oprea, Ştefan Barbu, Septimiu Voidăzan, Minodora Dobreanu
   
     
  4 Plasma phosphorylated neurofilament heavy chains as a potential marker for ischemic stroke patients
    Authors: Adina Huțanu, Smaranda Maier, Rodica Bălaşa, Oana Roxana Oprea, Ştefan Barbu, Septimiu Voidăzan, Minodora Dobreanu
   
     
  5 CXCL13 levels are more increased in cerebrospinal fluid and plasma of patients with acute infectious than in non-infectious diseases of the central nervous system
    Authors: Brîndușa Țilea, Septimiu Voidazan, Rodica Balasa, Adina Hutanu, Andrea Fodor
   
     
  6 A case of fatal acute intermittent porphyria: laboratory diagnosis and pathogenesis considerations
    Authors: Rodica Bălaşa, Smaranda Maier, Anca Moţăţăianu, Zoltan Bajko, Otilia Moldovan, Erzsébet Benedek
   
     
  7 Does the serum IL-17 titer influence the efficacy of interferon-β treatment in multiple sclerosis patients?
    Authors: Rodica Bălaşa, Adina Huţanu, Z. Bajko, Camelia Feier, I. Pascu
   
     
  8 Incidence and clinical significance of binding antibodies and their relationships with neutralizing antibodies, both induced by interferon-β treatment in multiple sclerosis patients
    Authors: Rodica Bălaşa, Adina Huţanu, Camelia Feier, Zoltan Bajko, Ion Pascu